HealthMyne successfully introduced its Quantitative Imaging Decision Support (QIDS)™ software platform at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, Ill.
The FDA-cleared QIDS (pronounced “quids”) software platform combines imaging data with electronic medical records, radiation therapy and other clinical systems information to provide clinical decision support in the primary read. Currently focused on radiology and oncology, with planned expansion into other specialties, QIDS is uniquely designed to positively impact clinical productivity and prepare radiologists for the transition to Value-Based Payment.
"Seeing the excitement around our product motivates us to finish 2016 on a high note and allows us to enter 2017 with significant tailwind."Arvind Subramanian, President and CEO of HealthMyne